AB
STIM icon

Amalgamated Bank’s Neuronetics STIM Stock Holding History

Amalgamated Bank’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,239
Closed -$2K – 2668
2025
Q4 		$2K Buy
1,239
+4
+0.3% +$8 ﹤0.01% 2923
2025
Q3 		$3K Hold
1,235
– – ﹤0.01% 2905
2025
Q2 		$4K Buy
+1,235
New +$4.88K ﹤0.01% 2881
2022
Q2 		– Sell
-4,043
Closed -$12K – 3190
2022
Q1 		$12K Buy
+4,043
New +$13.7K ﹤0.01% 2927

Other funds holding STIM

MAM
Madryn Asset Management New York $34.1M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Amalgamated Bank's STIM Position: Q1 2026 in Review

Amalgamated Bank sold out of Neuronetics (STIM) in Q1 2026, closing a stake of 1,239 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in STIM in Q1 2022 and held it in 4 quarters. The position peaked at $12K in Q1 2022. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • Amalgamated Bank reported no remaining Neuronetics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,239 Neuronetics shares in Q1 2026, an estimated $2K.
  • Amalgamated Bank first reported a position in Neuronetics in Q1 2022 and held it in 4 quarters.
  • Amalgamated Bank's Neuronetics position peaked at $12K in Q1 2022.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.